Shoulder Capsulitis
Conditions
Brief summary
A prospective randomized controlled study among 60 consecutive adhesive capsulitis to compare between the ultrasound-guided anterior hydrodilatation in rotator interval and the posterior approach.
Detailed description
patients was randomized into two equal groups. Group I received ultrasound-guided hydrodilatation with corticosteroid, saline, and local anesthetic via posterior intra-articular approach; group II received the same ultrasound-guided hydrodilatation via anterior rotator interval approach. Both groups received guided stretching exercises for 3 months after injection. Baseline and 3 months evaluation of pain by visual analogue scale (VAS), shoulder pain and disability index (SPADI), and range of motion (ROM) had been recorded for all patients. A statistical power analysis was performed after sample size estimation, based on data from the current study (N = 60), comparing group I to group II. Qualitative data was expressed as numbers and percentages, and Chi-squared test, Quantitative data were expressed as mean and standard deviation.
Interventions
Group I was treated through posterior approach; The injection needle is introduced at the skin surface just lateral to the transducer and in an oblique lateral to medial direction. Group II was treated through anterior rotator interval approach. A 21-gauge needle is introduced into the rotator interval using an oblique path within the imaging plane of the transducer; from lateral to medial, the needle tip is imaged in real time throughout its passage from superficial to deep and is positioned in the biceps tendon sheath between the coracohumeral ligament above and biceps tendon below. Both groups were given the same guided stretching and strengthening exercise program
corticosteroid, saline, and local anesthetic
guided stretching and strengthening exercise program
Sponsors
Study design
Masking description
the participants and outcome assessor didn't know the group classification
Eligibility
Inclusion criteria
* patients aged 35 to 60 years, * patients who suffered pain and stiffness in only one shoulder, for 1 to 6 months * patients who had restriction of passive motion.
Exclusion criteria
* patients with previous trauma, * patients with neurological * patients with endocrinal diseases * patients with shoulder tumor * patients with arthritis * people who had received intra-articular shoulder injection within the last 6 months. * Patients with tendon tear
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| visual analoge state | 3 months | minimum value: 0 maximum value: 10 higher scores mean a worse outcome. |
| shoulder pain and disability index | 3 months | minimum value: 0 maximum value: 100 higher scores mean a worse outcome. |
Countries
Egypt